Skip to content
ClinCalc Pro
Menu
endocrinology

CANRISK — Canadian Diabetes Risk Questionnaire

CANRISK (Public Health Agency of Canada) screens adults for prediabetes and undiagnosed type 2 diabetes from 15 questions. It was developed in adults aged 40–74; the Canadian Task Force uses ≥ 33 (high) and ≥ 43 (very high) to guide HbA1c screening.

Score interpretation

Low to Moderate Risk 0–32

CANRISK 0–32 — about 1–17 % chance of type 2 diabetes over 10 years.

→ Canadian Task Force: no routine screening; lifestyle advice; reassess if risk factors change.

High Risk 33–42

CANRISK 33–42 — about 33 % chance of type 2 diabetes over 10 years.

→ Screen with HbA1c every 3–5 years (Canadian Task Force); lifestyle programme; address cardiovascular risk factors.

Very High Risk 43–87

CANRISK ≥ 43 — about 50 % chance of type 2 diabetes over 10 years.

→ Screen with HbA1c every year (Canadian Task Force); structured diabetes prevention programme; address cardiovascular risk factors.

Interpretation bands for the CANRISK. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.